Agenus and dr. steven o'day to participate in webcast hosted by william blair on agen1181 and sitc data

Lexington, mass., nov. 13, 2020 (globe newswire) --  agenus inc. (nasdaq: agen), an immuno-oncology company with an extensive pipeline of checkpoint antibodies, cell therapies, adjuvants, and vaccines designed to activate immune response to cancers and infections, today announced that dr. steven o'day, executive director of the john wayne cancer institute, dr. jennifer buell, president and coo of agenus, and dr. dhan chand, scientific director head of drug discovery at agenus, will participate in a webcast hosted by dr. matt phipps of william blair on monday, november 16, 2020 at 10:00 a.m. et.
AGEN Ratings Summary
AGEN Quant Ranking